Diguanosine pentaphosphate: An endogenous activator of Rho-kinase possibly involved in blood pressure regulation

Journal of Hypertension

Volumn 24, Issue 10, 2006, Pages 1991-2000

  Tölle, Markus ^a   Giebing, Günter ^a   Tietge, Uwe J W ^a   Jankowski, Joachim ^a   Jankowski, Vera ^a   Henning, Lars ^a   Hörl, Matthias P ^a   Weiss, Wolfgang ^a   Zidek, Walter ^a   Van Der Giet, Markus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Blood pressure regulation; Dinucleoside polyphosphates; P2Y receptor; Rho kinase

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN II; GUANOSINE 3' DIPHOSPHATE 5' TRIPHOSPHATE; PURINE P2Y RECEPTOR; RHO KINASE;

ADULT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CYTOSOLIC FRACTION; ENZYMATIC ASSAY; ENZYME ACTIVATION; HUMAN; HYPERTENSION; KIDNEY PERFUSION; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEAN ARTERIAL PRESSURE; MUSCLE CONTRACTILITY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; WESTERN BLOTTING;

EID: 33748562838     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000244948.87911.05     Document Type: Article

References (38)

1. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003; 83:1325-1358.
2. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 2000; 522:177-185.
3. Kaibuchi K, Kuroda S, Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 1999; 68:459-486.
4. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273:245-248.
5. Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, et al. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 1997; 272:12257-12260.
6. Schluter H, Grobeta I, Bachmann J, Kaufmann R, van der Giet M, Tepel M, et al. Adenosine(5′) oligophospho-(5′) guanosines and guanosine(5′) oligophospho-(5′) guanosines in human platelets. J Clin Invest 1998; 101:682-688.
7. Tölle M, Giebing G, Schmidt S, Zidek W, van der Giet M. Activation of P2Y-receptors augments angiotensin II-induced vasconstriction. J Hypertens 2004; 22 (Suppl. 2):S45-S46.
8. Barnes LD, Robinson AK, Mumford CH, Garrison PN. Assay of diadenosine tetraphosphate hydrolytic enzymes by boronate chromatography. Anal Biochem 1985; 144:296-304.
9. Hillenkamp F, Karas M. Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization. Methods Enzymol 1990; 193:280-295.
10. Kaufman R, Kirsch D, Spengler B. Sequencing of peptides in a time-of-flight mass spectrometer: evaluation of postsource decay following matrix-assisted laser desorption ionisation (MALDI). Int J Mass Spectrom Ion Proc 1994; 131:355-385.
11. Jankowski J, Stephan N, Knobloch M, Fischer S, Schmaltz D, Zidek W, et al. Mass-spectrometry-linked screening of protein fractions for enzymatic activities - a tool for functional genomics.. Anal Biochem 2001; 290:324-329.
12. van der Giet M, Khattab M, Borgel J, Schluter H, Zidek W. Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol 1997; 120:1453-1460.
13. Schluter H, Offers E, Bruggemann G, van der Giet M, Tepel M, Nordhoff E, et al. Diadenosine phosphates and the physiological control of blood pressure. Nature 1994; 367:186-188.
14. Gong MC, Fujihara H, Somlyo AV, Somlyo AP. Translocation of RhoA associated with Ca2+ sensitization of smooth muscle. J Biol Chem 1997; 272:10704-10709.
15. Jankowski J, Hagemann J, Yoon MS, van der Giet M, Stephan N, Zidek W, et al. Increased vascular growth in hemodialysis patients induced by platelet-derived diadenosine polyphosphates. Kidney Int 2001; 59:1134-1141.
16. van der Giet M, Schmidt S, Tolle M, Jankowski J, Schluter H, Zidek W, et al. Effects of dinucleoside polyphosphates on regulation of coronary vascular tone. Eur J Pharmacol 2002; 448:207-213.
17. van der Giet M, Westhoff T, Cinkilic O, Jankowski J, Schluter H, Zidek W, et al. The critical role of adenosine and guanosine in the affinity of dinucleoside polyphosphates to P(2X)-receptors in the isolated perfused rat kidney. Br J Pharmacol 2001; 132:467-474.
18. Malam-Souley R, Seye C, Gadeau AP, Loirand G, Pillois X, Campan M, et al. Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J Cell Physiol 1996; 166:57-65.
19. Wang DJ, Huang NN, Heppel LA. Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J Cell Physiol 1992; 153:221-233.
20. Erlinge D. Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 1998; 31:1-8.
21. Erlinge D, Hou M, Webb TE, Barnard EA, Moller S. Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 1998; 248:864-870.
22. Van Der Giet M, Giebing G, Tolle M, Schmidt S. The role of P2Y receptors in the control of blood pressure. Drug News Perspect 2002; 15:640-646.
23. Turner CM, Vonend O, Chan C, Burnstock G, Unwin RJ. The pattern of distribution of selected ATP-sensitive P2 receptor subtypes in normal rat kidney: an immunohistological study. Cells Tissues Organs 2003; 175:105-117.
24. Bailey MA, Imbert-Teboul M, Turner C, Srai SK, Burnstock G, Unwin RJ. Evidence for basolateral P2Y(6) receptors along the rat proximal tubule: functional and molecular characterization. J Am Soc Nephrol 2001; 12:1640-1647.
25. Jankowski V, Tolle M, Vanholder R, Schonfelder G, van der Giet M, Henning L, et al. Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor. Nat Med 2005; 11:223-227.
26. Charlton SJ, Brown CA, Weisman GA, Turner JT, Erb L, Boarder MR. PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br J Pharmacol 1996; 118:704-710.
27. Miyagi Y, Kobayashi S, Nishimura J, Fukui M, Kanaide H. Dual regulation of cerebrovascular tone by UTP: P2U receptor-mediated contraction and endothelium-dependent relaxation. Br J Pharmacol 1996; 118:847-856.
28. Galle J, Mameghani A, Bolz SS, Gambaryan S, Gorg M, Quaschning T, et al. Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA. J Am Soc Nephrol 2003; 14:1471-1479.
29. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Vaillant N, Gadeau AP, Desgranges C, et al. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 2000; 278:H1751-H1761.
30. Jankowski M, Szczepanska-Konkel K, Kalinowski L, Angielski S. Involvement of Rho-kinase in P2Y-receptor-mediated contraction of renal glomeruli. Biochem Biophys Res Commun 2003; 302:855-859.
31. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372:231-236.
32. Cavarape A, Bauer J, Bartoli E, Endlich K, Parekh N. Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of Rho-kinase. Nephrol Dial Transplant 2003; 18:1764-1769.
33. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001; 38:1307-1310.
34. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389:990-994.
35. Chrissobolis S, Sobey CG. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C. Circ Res 2001; 88:774-779.
36. Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J, et al. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 2001; 15:1062-1064.
37. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 2003; 93:767-775.
38. Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int 2003; 64:2009-2019.